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Abstract
Background: Measuring and monitoring the true prevalence of risk factors for chronic conditions is essential for
evidence-based policy and health service planning. Understanding the prevalence of risk factors for cardiovascular
disease (CVD) in Australia relies heavily on self-report measures from surveys, such as the triennial National Health
Survey. However, international evidence suggests that self-reported data may substantially underestimate actual risk
factor prevalence. This study sought to characterise the extent of misreporting in a large, nationally-representative
health survey that included objective measures of clinical risk factors for CVD.
Methods: This study employed a cross-sectional analysis of 7269 adults aged 18 years and over who provided
fasting blood samples as part of the 2011–12 Australian Health Survey. Self-reported prevalence of high blood
pressure, high cholesterol and diabetes was compared to measured prevalence, and univariate and multivariate
logistic regression analyses identified socio-demographic characteristics associated with underreporting for each risk
factor.
Results: Approximately 16 % of the total sample underreported high blood pressure (measured to be at high risk
but didn’t report a diagnosis), 33 % underreported high cholesterol, and 1.3 % underreported diabetes. Among
those measured to be at high risk, 68 % did not report a diagnosis for high blood pressure, nor did 89 % of people
with high cholesterol and 29 % of people with high fasting plasma glucose. Younger age was associated with
underreporting high blood pressure and high cholesterol, while lower area-level disadvantage and higher income
were associated with underreporting diabetes.
Conclusions: Underreporting has important implications for CVD risk factor surveillance, policy planning and
decisions, and clinical best-practice guidelines. This analysis highlights concerns about the reach of primary
prevention efforts in certain groups and implications for patients who may be unaware of their disease risk status.
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Background
Effective and appropriate health system planning and
evaluation relies on accurate estimates of disease
prevalence. Cardiovascular disease (CVD) and diabetes
represent major causes of ill health in Australia and
have been National Health Priority Areas since the
1990s [1, 2]. CVD is a leading cause of death in
Australia, accounting for 13.9 % of the burden of disease
in 2010, while diabetes mellitus accounted for a further
2.3 % [3]. A substantial proportion of healthcare expend-
iture in Australia is directed toward CVD and diabetes,
with $7.6 billion (around 12 %) and $1.5 billion (2.3 %) of
2008–09 expenditure attributable to cardiovascular dis-
eases and diabetes, respectively [4, 5].
Population estimates of chronic disease and associated
risk factor rates are commonly based on self-report data
obtained via interview or questionnaire. Self-report data
can be obtained readily and at minimal expense for a
large population sample, but may not provide an accur-
ate indication of prevalence [6]. Evidence from several
international studies suggests that clinical risk factors
are frequently misreported [6–10], with respondents ei-
ther not reporting risks for which they have biomarkers
(underreporting), or reporting having risks for which
they lack biomarkers (overreporting). Apparent overre-
porting may be a result either of inaccurate reporting, or
of successful treatment of a condition (for instance, with
medication), causing biomedical results to appear nor-
mal. Conversely, underreporting may represent un-
known and therefore untreated risk at the individual
level. For health systems to effectively prevent chronic
conditions like CVD and diabetes, risks for and markers
of disease must first be detected and reported, to facili-
tate planning and response. For this reason, underre-
porting has important implications for surveillance and
health system planning and is the focus of this analysis.
Multiple factors may contribute to underreporting;
a patient may be unaware of their risk status if they
haven’t been diagnosed by a doctor; there may be
miscommunication between doctor and patient; or a
patient may choose not to report a known diagnosis
for various personal reasons [6, 11, 12]. The extent of
underreporting can be substantial and varies by risk
factor, country and socio-demographic characteristics
[6–10, 13, 14]. Risks factors that are rarely screened
for and that cause minimal symptoms are more likely
to be underreported [6].
Australian estimates of the prevalence of CVD risk
factors are largely reliant on self-report measures from
surveys such as the triennial National Health Survey
(Australian Bureau of Statistics, ABS), and administrative
data such as the National Hospital Morbidity Database
(Australian Institute of Health and Welfare) and the
National Diabetes Services Scheme (Diabetes Australia).
It is difficult to validate the prevalence estimates gener-
ated by these types of data sources without objective
measures such as blood tests, which necessitates a large-
scale biomedical survey. Such data became available in
Australia for the first time with the large, comprehen-
sive, and nationally-representative 2011–12 Australian
Health Survey (AHS).
The research questions informing this study were:
1. What is the extent of misreporting of cardiovascular
risk factors in Australia? and,
2. What socio-demographic characteristics are associ-
ated with underreporting?
Methods
Study sample
This analysis focuses on high blood pressure, high choles-
terol, and diabetes, which are all major risk factors for
CVD [15, 16]. It uses data from the core sample of the
2011–12 AHS, a nationwide, household survey consisting
of three arms: a general health survey, a nutrition and
physical activity survey, and a voluntary biomedical survey
which included participants from the first two arms. The
AHS used a multi-stage, stratified area sample of private
residences in both urban and rural areas, covering ap-
proximately 97 % of people living in Australia. Out of
30,721 households selected for the sample, 25,084 house-
holds (81.6 %) adequately responded. The core sample in-
cluded 31,837 persons, of whom 24,910 were adults aged
18 years and over [17]. Survey respondents were asked
whether they had ever been told by a doctor or nurse that
they had “high blood pressure or hypertension,” “high
cholesterol,” or “diabetes,” and whether the condition was
current and long-term. Trained interviewers took blood
pressure readings. All adult core sample respondents were
invited to participate in the biomedical survey and 7582
(30.4 %) ultimately provided a fasting blood sample.
Detailed information on survey structure, design and sam-
pling can be found in the AHS Users’ Guide [17].
Results were analysed for 7269 non-pregnant adults
aged 18 years and over who had valid readings for blood
pressure, total cholesterol, and fasting plasma glucose
(FPG). High measured blood pressure was defined as a
reading greater than or equal to 140/90 mmHg [18].
High measured cholesterol was defined as a total blood
cholesterol reading greater than or equal to 5.5 mmol/L
[19]. A FPG level greater than or equal to 7.0 mmol/L
was considered indicative of diabetes [20]. As FPG tests
cannot differentiate types of diabetes, this analysis
grouped self-reported type 1 and type 2 diabetes melli-
tus. Data on treatment for long-term conditions were
not available, therefore this study did not include an
analysis of whether respondents were being treated for
reported conditions.
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Statistical analysis
For each risk factor, self-reported prevalence was tabu-
lated against the relevant biomedical indicator to deter-
mine reporting accuracy. A two-proportion z test was
used to determine whether any difference between self-
reported and measured prevalence was statistically
significant. Kappa statistics were generated to indicate
the level of agreement between self-reported and mea-
sured data. Univariate logistic regression models were
used to calculate the odds of underreporting according
to socio-demographic characteristics. Multivariate logis-
tic regression models were developed to analyse concur-
rent associations between different socio-demographic
characteristics. Sample weights provided by the ABS for
the biomedical survey were applied in order to bench-
mark the biomedical sample to the 31 October 2011 es-
timated resident population as described in the AHS
User’s Guide [17]. Variables associated with underreport-
ing in univariate analysis at p < 0.25 were included in the
multivariate model in a forward, step-wise procedure as
described by Bursac et al. [21], and were retained in the
final adjusted model if they improved the model fit.
Outcome variables
Underreporting was calculated by dividing the number
of people who had biomarkers for a given risk factor but
did not report it, by the total number of people with
biomarkers for that risk factor. For the purposes of the
logistic regression, a binary outcome variable was gener-
ated with people who accurately reported disease being
coded as 0 and underreporters coded as 1. Overreport-
ing was calculated by dividing the number of people
who reported a given risk factor but lacked biomarkers
for it, by the total number of people who reported being
diagnosed with that risk factor. As underreporting is the
main concern of this analysis, overreporting was not in-
cluded in the logistic regression.
Socio-demographic variables
Socio-demographic characteristics included sex, age,
education (highest year of school completed), equivalised
weekly household income, whether born in Australia,
self-rated English proficiency, area-level socio-economic
status and remoteness. The effect of age on underreport-
ing was analysed in two ways: once with age as a con-
tinuous variable, with the odds ratio reported per 1 year
increase in age, and once with age divided into three
groups (18–44 years old, 45–64 years old, and 65 years
and over) to reflect Australian clinical practice guidelines
[22], which recommend separate preventive actions in
“middle aged” adults (defined as 45–64 years) and “older
aged” adults (defined as 65 years and over).
The ABS Index of Relative Socio-economic Disadvan-
tage (IRSD) was used as an indicator of relative area-
level socioeconomic status. IRSD summarises a range of
census information about the economic and social con-
ditions of people and households within an area [23].
Remoteness was defined according to the ABS Austra-
lian Statistical Geographic Standard (ASGS) remoteness
classification system, a geographical structure which
classifies areas sharing common characteristics of re-
moteness into five groups: major cities, inner regional,
outer regional, remote, and very remote [24]. This ana-
lysis differentiated between major cities, inner regional
areas, and all other areas (outer regional, remote and
very remote). All analyses used expanded confidentia-
lised unit record files of the AHS core sample and were
conducted within the ABS’s Remote Access Data
Laboratory [25] with queries submitted in Stata 10 ana-
lytical language. A p-value <0.05 was used as a threshold
for determining statistical significance of the multivariate
models.
Results
Approximately 55 % of the sample was female, and the
mean age was 51.9 (standard deviation 0.2) years
(Table 1). The majority of respondents were in the 45–
64 year age group (41 %) and lived in major cities
(61 %). Almost half had completed year 12 or equivalent
education, while another 40 % had completed only year
10 or below.
Self-reported and measured prevalence of risk factors
Self-reported prevalence was lower than measured
prevalence for high blood pressure (17.4 and 23.9 %,
respectively) and high cholesterol (12.2 and 37.3 %, re-
spectively) (Table 2). For diabetes, 6.1 % of people self-
reported having diabetes, but only 4.5 % were measured
to have elevated blood glucose levels. The difference
between self-reported and measured prevalence was sta-
tistically significant for both sexes for all three risk fac-
tors. Figure 1 presents the measured prevalence in (a)
males and (b) females, by age group. The prevalence of
high blood pressure and diabetes increased with age for
both sexes, while high cholesterol was most prevalent in
the 45–64 year age group.
Misreporting
While the majority of people were correct about not
having a given risk factor, both underreporting and over-
reporting were present for all three risk factors (Table 2).
Just under 8 % of people had high blood pressure and
accurately reported it, while 4.1 and 3.2 % accurately
reported high cholesterol and diabetes, respectively.
Figure 2 gives a graphical representation of the amount
of overlap between self-reported and measured risk fac-
tors. Participants measured to have risk factors were
often not the same people who self-reported having risk
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factors, especially for high cholesterol, indicating that
the extent of misreporting at the individual level was
greater than the overall differences between self-report
and measured prevalence would suggest. Kappa statistics
were calculated to measure the agreement between self-
reported and measured data, and were 0.21 (95 % CI:
0.18–0.23) for high blood pressure and −0.02 (−0.04–
0.01) for high cholesterol, indicating low agreement, and
0.58 (0.54–0.62) for diabetes, indicating moderate agree-
ment using the scale recommended by Landis and Koch
(1977) [26].
Approximately 16.4 % of all respondents underre-
ported high blood pressure, 33.2 % underreported high
cholesterol, and 1.3 % underreported diabetes. Among
those measured to have each risk factor, a large propor-
tion did not self-report (Table 2). The proportion of
people with high measured blood pressure who failed to
report it was 68.4 % (66.2–70.6 %). Of those with high
measured total cholesterol, 89.0 % (87.9–90.2 %) did not
report a diagnosis of high cholesterol. Of people with
elevated FPG, 28.6 % (23.7–33.6 %) did not report a
diagnosis of diabetes. On the other hand, of those who
self-reported high blood pressure and high cholesterol,
the majority did not have biomarkers (56.5 % overre-
ported high blood pressure and 66.6 % overreported
high cholesterol). Almost half of those who self-reported
diabetes (48.0 %) did not have FPG levels indicating
diabetes.
Socio-demographic factors associated with
underreporting
Univariate logistic regression analysis showed that the
older age groups had significantly lower odds of under-
reporting high blood pressure than the 18–44 age group,
with an odds ratio in the 45–64 year age group of 0.4
(95 % CI 0.2–0.6) and in the 65 and over age group of
0.2 (0.1–0.3) (Table 3). When age was treated as a con-
tinuous variable, the odds ratio for underreporting cor-
responding to each full-year increase in age from
18 years was 0.96 (0.95–0.97). Higher education level
was associated with greater underreporting of high blood
pressure; the odds of underreporting in the highest
education group (finished year 12 or above) were 1.7
(1.2–2.5) times higher than in those who had finished
only year 9 or below. In the group who finished year 11 or
below, the odds were 2.3 (1.4–4.0) times higher than the
lowest education group. Higher equivalised household
Table 1 Socio-demographic characteristics of the study sample
Male
(n = 3275)
Female
(n = 3994)
All
(n = 7269)
% % %
Mean age, years (SD) 52.5 (0.3) 51.4 (0.3) 51.9 (0.2)
Age groups
18–44 32.8 35.7 34.4
45–64 41.0 40.2 40.6
65+ 26.1 24.1 25.0
ASGS remoteness classification
Major cities 60.8 61.2 61.0
Inner regional areas 22.8 22.6 22.7
Other areas 16.4 16.2 16.3
Equivalised household income
Quintile 1 (lowest income) 16.1 19.5 18.0
Quintile 2 18.1 21.0 19.7
Quintile 3 19.9 19.6 19.7
Quintile 4 22.2 21.3 21.7
Quintile 5 (highest income) 23.7 18.6 20.9
IRSD (area-level disadvantage)
Quintile 1
(highest disadvantage)
18.1 18.2 18.1
Quintile 2 19.3 20.4 19.9
Quintile 3 20.9 20.6 20.7
Quintile 4 20.8 20.1 20.4
Quintile 5
(lowest disadvantage)
20.9 20.7 20.8
Highest year of school completed
Year 9 or below 16.4 15.2 15.8
Year 10 or equivalent 24.6 24.6 24.6
Year 11 or equivalent 10.0 9.5 9.7
Year 12 or equivalent 49.0 50.7 49.9
Region of birth
Australia 69.9 72.3 71.2
Northwest Europe 12.7 10.6 11.6
Oceania and Antarctica
(excluding Australia)
3.5 3.3 3.4
Southeast Asia 2.7 3.5 3.2
Southern and Eastern Europe 2.7 3.0 2.9
Southern and Central Asia 2.6 2.0 2.3
Sub-Saharan Africa 1.6 1.5 1.6
Northeast Asia 1.6 1.5 1.6
Americas 1.5 1.3 1.4
North Africa and Middle East 1.1 0.9 1.0
English proficiency
Very well or mainly speaks
English at home
95.6 95.2 95.4
Well 3.3 3.4 3.4
Table 1 Socio-demographic characteristics of the study sample
(Continued)
Not well or not at all 1.1 1.4 1.2
Notes: Columns may not sum to 100 % due to rounding artefacts. ASGS
Australian Statistical Geography Standard, IRSD Index of Relative Socio-
economic Disadvantage, SD standard deviation
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income was also associated with greater underreporting of
high blood pressure, with an odds ratio of 1.9 (1.2–3.1) in
the second highest and 2.4 (1.5–3.8) in the highest
income group compared to the lowest income group.
However, household income was found to be corre-
lated with age (rS < −0.34), education (rS < −0.37), and
area-level disadvantage (rS > 0.32), and its inclusion in
the multivariate analysis did not improve the fit of
the final model, therefore it was excluded from the
final multivariate model. In the fully-adjusted multi-
variate logistic regression model for high blood
pressure, age remained significantly associated with
underreporting (Table 4). No other variables remained
significant, though the overall model, which also in-
cluded sex and education, was significant (p < 0.001).
Older age was also associated with lower odds of
underreporting high cholesterol. The odds of underre-
porting high cholesterol in both the 45–64 and the 65
and over age groups was half that of the 18–44 year age
group (45–64 years: 0.5 (0.3–0.7); 65 years and over: 0.5
(0.3–0.8)). When treated as a continuous variable, each
year increase in age was associated with an odds ratio of
0.98 (0.97–0.99). Higher education level was associated
with increased odds of underreporting high cholesterol.
People who finished year 12 or above had 1.8 (1.2–2.9)
times the odds of underreporting when compared to
people who had only finished year 9 or below. In the
Table 2 Prevalence of risk factors, accuracy of reporting, and rates of misreporting
High blood
pressure
High
cholesterol
Diabetes
Prevalence Self-reported 17.4 (16.5–18.3) 12.2 (11.5–13.0) 6.1 (5.6–6.7)
Measured to have risk factor 23.9 (22.9–24.9)* 37.3 (36.2–38.4)* 4.5 (4.0–4.9)*
Accuracy of self-report Overreported: Self-reported but no measured risk factor 9.8 (9.1–10.5) 8.1 (7.5–8.8) 2.9 (2.6–3.3)
Underreported: Measured to have risk factor but did not self-report 16.4 (15.5–17.2) 33.2 (32.1–34.3) 1.3 (1.0–1.5)
Accurate, has disease: Self-reported and measured to have risk factor 7.6 (7.0–8.2) 4.1 (3.6–4.5) 3.2 (2.8–3.6)
Accurate, does not have disease: Did not self-report and no measured
risk factor
66.3 (65.2–67.3) 54.6 (53.4–55.7) 92.6 (92.0–93.2)
Misreporting rate Proportion of those measured to have risk factor that did not self-report 68.4 (66.2–70.6) 89.0 (87.9–90.2) 28.6 (23.7–33.6)
Proportion of those who self-reported that had no measured risk factor 56.5 (53.8–59.2) 66.6 (63.5–69.7) 48.0 (43.3–52.6)
Notes: Proportion of people (95 % confidence intervals in brackets)
*The difference between self-reported and measured prevalence was statistically significant (p < 0.001)
Fig. 1 Total population prevalence of measured high blood
pressure, high total cholesterol, and elevated fasting plasma glucose,
by sex and age group. a Males. b Females. Notes: BP blood pressure,
TC total serum cholesterol, FPG fasting plasma glucose
Fig. 2 Prevalence of overreporting, accurate reporting, and
underreporting, by risk factor
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fully-adjusted model, however, only being in the youn-
gest age group remained significantly associated with
underreporting, though the model was significant to the
p < 0.01 level with education, sex and English proficiency
also accounted for.
Male sex, higher household income and lower area-
level disadvantage were significantly associated with
underreporting diabetes in univariate analysis, but age
was not. The odds of underreporting were 50 % lower
among females compared to males (0.5 (0.2–1.0)). The
Table 3 Univariate logistic regressions of factors associated with underreporting
High blood pressure High cholesterol Diabetes
OR 95 % CI OR 95 % CI OR 95 % CI
Sex
Male 1.0 (ref) 1.0 (ref) 1.0 (ref)
Female 0.9 (0.7–1.2) 1.1 (0.8–1.6) 0.5 (0.2–1.0)*
Age (per year increase in age from age 18) 0.96 (0.95–0.97)** 0.98 (0.97–0.99)** 0.99 (0.96–1.02)
Age group
18–44 years 1.0 (ref) 1.0 (ref) 1.0 (ref)
45–64 years 0.4 (0.2–0.6)** 0.5 (0.3–0.7)** 1.2 (0.4–4.0)
65+ 0.2 (0.1–0.3)** 0.5 (0.3–0.8)** 0.8 (0.2–2.5)
ASGS remoteness classification
Major cities 1.0 (ref) 1.0 (ref) 1.0 (ref)
Inner regional areas 0.9 (0.6–1.3) 1.0 (0.6–1.4) 1.0 (0.4–2.5)
Other areas 1.0 (0.6–1.5) 1.1 (0.6–1.8) 0.7 (0.3–1.7)
Equivalised household income
Quintile 1 (lowest income) 1.0 (ref) 1.0 (ref) 1.0 (ref)
Quintile 2 1.0 (0.7–1.5) 0.9 (0.5–1.6) 1.0 (0.4–2.6)
Quintile 3 1.6 (1.0–2.6) 0.8 (0.5–1.4) 4.1 (1.5–10.8)**
Quintile 4 1.9 (1.2–3.1)** 1.2 (0.7–2.0) 2.9 (1.0–8.5)
Quintile 5 (highest income) 2.4 (1.5–3.8)** 1.0 (0.6–1.7) 3.4 (1.1–10.7)*
IRSD (area-level disadvantage)
Quintile 1 (highest disadvantage) 1.0 (ref) 1.0 (ref) 1.0 (ref)
Quintile 2 0.9 (0.6–1.5) 1.0 (0.6–1.8) 2.5 (0.8–7.8)
Quintile 3 1.0 (0.6–1.5) 1.3 (0.7–2.3) 1.0 (0.3–3.3)
Quintile 4 0.9 (0.6–1.5) 0.9 (0.5–1.6) 2.8 (0.9–8.3)
Quintile 5 (lowest disadvantage) 1.4 (0.8–2.2) 0.9 (0.5–1.7) 4.1 (1.4–12.3)*
Education level
Year 9 or below 1.0 (ref) 1.0 (ref) 1.0 (ref)
Year 10 or equivalent 1.2 (0.8–1.8) 1.3 (0.8–2.1) 1.4 (0.5–3.8)
Year 11 or equivalent 2.3 (1.4–4.0)** 1.5 (0.8–2.7) 1.8 (0.5–6.0)
Year 12 or equivalent 1.7 (1.2–2.5)** 1.8 (1.2–2.9)** 1.0 (0.4–2.7)
English Proficiency
Fluent 1.0 (ref) 1.0 (ref) 1.0 (ref)
Not fluent 1.2 (0.6–2.5) 0.7 (0.3–1.3) 2.7 (0.7–10.1)
Country of birth
Australia 1.0 (ref) 1.0 (ref) 1.0 (ref)
Not Australia 1.2 (0.9–1.6) 1.0 (0.7–1.4) 1.1 (0.5–2.3)
Notes: CI 95 % confidence interval, IRSD Index of Relative Socio-economic Disadvantage, OR odds ratio, ref reference group
*Group significantly different from reference group (p < 0.05)
**Group significantly different from reference group (p < 0.01)
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odds of underreporting were 3.4 (1.1–10.7) times higher
in the highest household income quintile versus the low-
est quintile. Likewise, people living in areas with the
lowest disadvantage (IRSD quintile 5) had 4.1 (1.4–12.3)
times the odds of underreporting diabetes compared to
those living in the most disadvantaged areas (IRSD quin-
tile 1). Though household income was collinear with
IRSD, the multivariate model had a better fit when both
variables were included. Household income quintile 3
was significantly associated with greater odds of under-
reporting (3.7 (1.3–10.7)), as was IRSD quintile 5 (3.7
(1.3–11.0)). Sex and English proficiency were also in the
model, but were not significant.
Discussion
In this representative sample of Australian adults, both
underreporting and overreporting were prevalent for all
three risk factors. The combined effect of underreport-
ing and overreporting was such that the self-reported
prevalence of high blood pressure, high cholesterol, and
diabetes did not appear to be vastly different from the
measured prevalence, yet there was minimal overlap be-
tween people reporting risk factors and those measured
to have them. Furthermore, kappa statistics indicated
low agreement between self-reported and measured data.
Both high blood pressure and high cholesterol were
highly prevalent in the study population, and rates of
Table 4 Multivariate logistic regressions of factors associated with underreporting
High blood pressure High cholesterol Diabetes
OR 95 % CI OR 95 % CI OR 95 % CI
Sex
Male 1.0 (ref) 1.0 (ref) 1.0 (ref)
Female 1.1 (0.8–1.4) 1.3 (0.9–1.8) 0.6 (0.3–1.3)
Age group
18–44 years 1.0 (ref) 1.0 (ref) Not in model
45–64 years 0.4 (0.2–0.6)*** 0.5 (0.3–0.7)**
65+ 0.2 (0.1–0.3)*** 0.5 (0.3–0.8)*
Equivalised household income
Quintile 1 (lowest income) Not in model Not in model 1.0 (ref)
Quintile 2 1.0 (0.4–2.7)
Quintile 3 3.7 (1.3–10.7)*
Quintile 4 2.4 (0.8–7.1)
Quintile 5 (highest income) 2.7 (0.8–8.8)
IRSD (area-level disadvantage)
Quintile 1 (highest disadvantage) Not in model Not in model 1.0 (ref)
Quintile 2 1.9 (0.7–5.6)
Quintile 3 0.8 (0.3–2.7)
Quintile 4 2.2 (0.7–7.1)
Quintile 5 (lowest disadvantage) 3.7 (1.3–11.0)*
Education level
Year 9 or below 1.0 (ref) 1.0 (ref) Not in model
Year 10 or equivalent 0.9 (0.6–1.4) 1.1 (0.7–1.8)
Year 11 or equivalent 1.7 (1.0–3.0) 1.3 (0.7–2.3)
Year 12 or equivalent 1.0 (0.7–1.6) 1.5 (0.9–2.3)
English Proficiency
Fluent Not in model 1.0 (ref) 1.0 (ref)
Not fluent 0.6 (0.3–1.1) 3.6 (0.9–14.5)
p-value of model p < 0.001 p < 0.01 p < 0.001
Notes: CI confidence interval, IRSD Index of Relative Socio-economic Disadvantage, OR odds ratio, ref reference group
*Group significantly different from reference group (p < 0.05)
**Group significantly different from reference group (p < 0.01)
***Group significantly different from reference group (p < 0.001)
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under and overreporting were comparable for both, as
were the characteristics of those most likely to underre-
port each risk factor. Approximately 16.4 % of the total
sample had high blood pressure but didn’t report it,
33.2 % failed to report high cholesterol, and 1.3 % failed
to report diabetes. The majority of people measured to
have high blood pressure and high cholesterol did not
report any diagnosis, while nearly one-third of those
with impaired FPG did not report diabetes. Underreport-
ing was most prevalent in those with higher SES (for
diabetes) and in younger adults (for blood pressure and
cholesterol).
Underreporting could be due to any of several factors.
The individual may not experience symptoms and may
not seek medical care; their doctor may not screen for a
risk factor or may decide not to diagnose; a diagnosis
may be miscommunicated or forgotten; or an individual
may choose not to report for various personal reasons
[6, 11, 12]. People from more disadvantaged areas and
lower income households had lower odds of underre-
porting diabetes, contrary to expected results. People of
higher socio-economic status (SES) could reasonably be
expected to have greater access to resources, more fre-
quent contact with the health system, and better rates of
diagnosis. Higher underreporting in people of higher
SES may be evidence of a social desirability bias, wherein
people of higher SES feel more compelled to conform to
a ‘healthy norm.’ This phenomenon has been demon-
strated in many survey situations [6], but is yet to be val-
idated within the Australian context.
Older adults were significantly more likely to report
high blood pressure or high cholesterol than were youn-
ger adults, despite both risk factors being prevalent in
the 18–44 year age group (Fig. 1). One potential explan-
ation could be that younger adults have less contact with
the health system than older adults, a phenomenon doc-
umented in the US [27] and Australia [28]. Young adults
may not feel unwell or expect to be suffering from
chronic diseases that are more commonly associated
with older age, and therefore may not seek care. High
blood pressure and high cholesterol increase the risk of
atherosclerosis, but the effects of atherosclerotic disease
accrue gradually over one’s lifetime and may not cause
symptoms in younger adults [29]. The young may also
be less likely to be tested for chronic disease risk factors
when they do contact the health system [30, 31]. Data
from the US have shown substantially lower rates of
awareness, treatment and control of hypertension in
adults aged 18–39 years with high blood pressure versus
those aged 40 years and over [32].
Underreporting was particularly pronounced for high
cholesterol, with nearly 90 % of people with high serum
cholesterol levels not reporting any diagnosis, and youn-
ger adults had significantly lower odds of reporting
compared to older adults. In Australia, regular choles-
terol tests are currently only recommended for people
aged 45 years and over [22]; it is likely that people in the
younger age group did not have cholesterol levels regu-
larly tested. Primary prevention of disease relies on early
detection of risk in order to halt progress from risk to
disease. The measured prevalence of high cholesterol
was 32 % in the 18–44 age group, representing risk for
atherosclerosis later in life, yet few of these people re-
ported being aware that they had this risk factor. This
result suggests that it may be appropriate to review clin-
ical guidelines and to consider recommending that
screening for high cholesterol begins earlier in adult-
hood. Furthermore, underreporting was exceptionally
high in all adults aged 45 and over who had high mea-
sured cholesterol, suggesting that even with targeted
clinical practice guidelines, the large majority of adults
remain unaware of their risk status.
Underreporting likely represents risk in the popula-
tion that is not being detected by the health system,
with implications for individuals and their families, as
well as for the wider health system. The data collected
within the AHS do not allow for in-depth analysis into
which factors might have influenced misreporting in
this sample, but it is likely that the underlying causes
will differ by socio-demographic factors. Non-uniform
rates of misreporting have significant implications for
health promotion efforts and policy decisions, particu-
larly those aimed at reducing health inequalities. Misre-
porting also has implications for health system
planning, which relies on accurate estimates of current
and future burden of disease.
Strengths and limitations
While the 2011–12 AHS had a high household response
rate (81.6 %) [17] and is nationally-representative, the
sample for this analysis was limited to the voluntary bio-
medical component. A biomedical sample weight was
applied to the logistic regression analysis to account for
the complex sampling design. However, it is possible
that a response bias was present in the study subsample
when compared to the core sample. Indeed, only 30.4 %
of invited adults provided fasting blood samples. How-
ever, a comparison between the biomedical subsample
and the core sample (available in the AHS users’ guide
[17]) shows that participants in the biomedical compo-
nent did not differ greatly from the wider sample with
respect to measured demographic characteristics and
risk factor profiles.
Some aspects of this analysis were limited by the
breadth of data collected in the original survey. Respon-
dents were asked to report any current, long-term con-
ditions and were prompted for specific conditions, but
were not provided with definitions or clarification for
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each condition. This may lead to misreporting if respon-
dents were unsure whether a diagnosis qualified to be
reported (for example, a patient with a systolic blood
pressure of 130 being told their blood pressure is on the
high side may or may not think this qualifies as “high
blood pressure”).
Further, the analysis was limited by a lack of treatment
(medication) information for the full, biomedical sample.
For this reason, data on apparent overreporting, while
included here for completeness, must be interpreted
with caution. Participants who reported risk factors but
lacked biomarkers did not necessarily ‘misreport’ or
‘overreport’. They may well have been diagnosed with
the risk factor by a health professional, despite bio-
markers being currently absent. The inability to take into
account whether respondents were on medication for
the included risk factors could lead to apparent overre-
porting if medication is effectively keeping patients’ bio-
marker levels below clinical thresholds. Other healthy
lifestyle changes following a diagnosis could also have
improved biomarker levels. Despite these concerns, mea-
sured biomarker levels represent the best ‘gold standard’
available for determining the validity and accuracy of
self-report data for chronic conditions [6]. Indeed, the
use of objective, biomedical data as a comparator of self-
reported data is a key strength of this study. Many stud-
ies compare self-reports to hospital or physician records,
which may be subject to various additional types of bias
or error [33]. Additionally, this study used a large and
nationally-representative sample, further strengthening
the results, and is the first such analysis of CVD risk fac-
tors to be conducted in Australia.
It is well documented that Australians in regional and
remote areas suffer limited access to health services
compared to their urban counterparts [34] and therefore
might be expected to be less aware of their risk status;
however, this study did not show any association be-
tween underreporting and remoteness. This finding may
warrant further investigation, as despite known limita-
tions in health care access, the result suggests that the
services available and accessed may be having at least a
comparable impact to that offered in major cities.
The prevalence rates and rates of underreporting
found in this study were comparable to those reported
in previous studies in a variety of international settings,
though most have focused on elderly populations. The
measured prevalence rates of each risk factor observed
in this study were similar to, though higher than, those
reported in another Australian study exploring risk fac-
tors in a workplace environment [35]. While the mea-
sured prevalence rates of high blood pressure, high
cholesterol, and impaired FPG in the current study were
24, 37, and 4.5 %, respectively, Freak-Poli et al. (2010)
reported prevalence rates of 18, 28, and 2 %. However,
there were important differences between the sample
characteristics; the sample in the Freak-Poli study was
an average of 12 years younger than the AHS sample
used for this study, was more highly educated (80 % with
tertiary education versus only 50 % completing year 12
or more), and 100 % were employed (versus 67 % in the
AHS sample). Similar to previous studies in Taiwan and
Denmark, the rate of misreporting in the current ana-
lysis varied depending on the risk factor [7, 8]. Measured
prevalence rates of high blood pressure have been
demonstrated to be 7–20 percentage points higher than
self-reported rates [7, 8, 12, 13, 36, 37]. Reporting of
high cholesterol has been less frequently validated, but
differences in the order of 30 percentage points between
self-reported and measured population prevalence were
demonstrated in the US [12, 36]. Diabetes self-reported
and measured prevalence rates are often within one
percentage point of each other, similar to the results
found here [6–8].
Misreporting, and particularly underreporting, are of
great concern from an individual, clinical and public
health perspective. While self-reported measures are
easy to collect, this analysis indicates that they may be
failing to provide an accurate picture of the risk and
burden of CVD in Australia, which has implications for
surveillance and policy planning and decisions. This ana-
lysis raises questions about the effectiveness and reach
of primary prevention efforts in certain demographic
groups and potential implications for patients who may
be unaware of their disease risk status. The relationships
between both age and socio-economic indicators and
underreporting should be further explored to identify
the reasons for high levels of underreporting in particu-
lar demographic groups.
Conclusions
This study found a substantial amount of misreporting
of high blood pressure and high cholesterol, and to a
lesser extent, of diabetes. Health system planning, both
in the short and long-term, relies on effective surveil-
lance of risk and disease in the population. Inaccurate
estimates of prevalence could lead to shortages of re-
sources or overspending. Furthermore, failure to provide
primary or secondary prevention and care could place
substantial sections of the population at risk of develop-
ing heart disease and diabetes complications, and subse-
quent loss of quality of life.
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